Pneumococcal Vaccine Approved by FDA
Prevnar to Be Available Soon
WASHINGTON, DC-The Food and Drug Administration (FDA) has approved Prevnar, manufactured by American Home Products Corporation, as a vaccine to prevent pneumococcal diseases in infants and toddlers. The vaccine would be issued as a series of four inoculations given at 2, 4, 6, and 12-15 months of age to prevent invasive diseases caused by Streptococcus pneumoniae including bacteremia and meningitis. Prevnar has not been approved for preventing ear infections, another product of pneumococcus, however American Home Products Corporation hopes it will soon be able to submit conclusive data to the FDA for approval.
The Commissioner of Food and Drugs, Dr. Jane Henney, states, "This new vaccine is great news for parents and children because now, for the first time, we have a highly effective way to prevent a major cause of meningitis and serious blood infections in the most susceptible children-those under two years of age. When we prevent these infections, we are also preventing brain damage and mortality from pneumococcal diseases."
The Advisory Committee on Immunization Practices (ACIP), an advisory committee for the Centers for Disease Control and Prevention, voted to recommend the use of Prevnar for all children up to age 23 months. APIC also recommended some older children ages 24-59 months be vaccinated with Prevnar, including African Americans, Native Americans, Alaskan Natives, or children who have sickle cell anemia, HIV, chronic diseases, or are immunocompromised.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
